Trend/momentum: MACD histogram is negative (-0.0138) and expanding lower, indicating bearish momentum is strengthening.
RSI(6)=26.49 suggests near-term oversold conditions (bounce is possible), but oversold alone is not a reliable buy trigger without confirmation.
Moving averages are converging, which often precedes a larger move; with MACD bearish, risk skews toward a breakdown.
Key levels: Support S1=$0.563 (then S2=$0.514); resistance/pivot at $0.643, then R1=$0.724. Current price ($0.587) is below pivot and closer to support.
Pattern-based forward odds are unfavorable: similar-pattern stats imply a negative drift over 1 week (-4.95%) and 1 month (-10.37%) on average.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Open interest put/call ratio = 0.11 (very call-heavy), implying bullish/speculative positioning.
Liquidity/confirmation: Today’s options volume is 0 (calls 0, puts 0), so current-day sentiment confirmation is absent.
Volatility: 30D IV is extremely elevated (530.58) with IV percentile 88.45; this reflects high uncertainty and expensive option pricing.
Open interest totals are modest (calls 1,782 vs puts 201), which can make the chain less reliable for sentiment reads.
Technical Summary
Sell
9
Buy
4
Positive Catalysts
suggests market participants are positioned for upside (though not confirmed by volume today).
Neutral/Negative Catalysts
Bearish momentum is building: MACD negative and worsening, and price is below the key pivot ($0.643).
Pattern-based outlook skews negative over the next week/month.
Latest quarter revenue contraction is severe (-44.65% YoY), which can weigh on sentiment and limit sustainable rallies.
News provided appears unrelated (mentions DarkIris Inc, not ClearSign/CLIR), so there is no clear stock-specific catalyst in the feed.
No hedge fund/insider accumulation signals recently; trading trends are neutral.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: $1.029M, down -44.65% YoY (clear growth deterioration).
Net income: -$1.429M (loss), but improved 23.72% YoY (loss narrowing).
EPS: -$0.03, improved 50% YoY.
Gross margin: 35.76%, up 20.65% YoY (positive efficiency trend, but not enough to offset revenue decline).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data was provided, so recent upgrades/downgrades and target revisions cannot be confirmed.
Wall Street pros (inferred from available data): improving gross margin and narrowing losses.
Wall Street cons (inferred from available data): sharp YoY revenue decline and weak/unclear catalyst support in the current news feed.
Influential/political flows: no recent congress trading data available; hedge funds and insiders show neutral activity.
Wall Street analysts forecast CLIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLIR is 2 USD with a low forecast of 2 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CLIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLIR is 2 USD with a low forecast of 2 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
